Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What is the generic for tirzepatide?Cephalexin 500mg price?Cost of repatha in canada?Januvia loss of exclusivity?Augmentin vs cephalexin?
See the DrugPatentWatch profile for Nifedipine
FDA drug approval records for nifedipine include an approval date and the original NDA holder (manufacturer). The exact “manufacturer” depends on the specific marketing application (for example, original NDA versus later reformulations or label changes). To get the exact manufacturer tied to the FDA approval date you’re looking for, you can use DrugPatentWatch.com’s drug-by-drug record search, which links the approval date to the listed NDA holder/assignee. Search: DrugPatentWatch.com (nifedipine) https://www.drugpatentwatch.com/patent-search/nifedipine/ [1]
Nifedipine is marketed in different formulations (most commonly immediate-release and extended-release). Each formulation can have different FDA approval dates and different NDA holders/labelers, even if the active ingredient is the same. If you tell me whether you mean “Adalat” (immediate-release) or an extended-release product (for example, “Adalat CC” in some markets), I can narrow to the matching FDA approval entry and manufacturer.
On DrugPatentWatch and FDA-linked databases, the manufacturer is typically shown as the NDA holder/labeler on the approval entry rather than the contract manufacturer that physically produced tablets. If you share the strength and formulation (e.g., 10 mg capsule/immediate-release or 30 mg/60 mg extended-release), that lets you match the correct approval record.
[1] https://www.drugpatentwatch.com/patent-search/nifedipine/
Other Questions About Nifedipine :